The Effect of Single Value Positivity in 100 g OGTT on Maternal and Fetal Outcomes

Objective & Hypothesis:Objective: In this study, we aimed to evaluate the obstetric and perinatal outcomes of a single value positivity in the 100 gram Oral Glucose Tolerance Test (OGTT).

📊

Key Findings & Data:Materials and Methods: 80 patients with single positivity of 100 gr OGTT, and 122 control patients with normal fasting blood glucose and 50 gr OGTT were included to this retrospective study.

💡

Conclusion & Impact:The number of fetuses with a 1st minute apgar score

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to evaluate the obstetric and perinatal outcomes of a single value positivity in the 100 gram Oral Glucose Tolerance Test (OGTT). Materials and Methods: 80 patients with single positivity of 100 gr OGTT, and 122 control patients with normal fasting blood glucose and 50 gr OGTT were included to this retrospective study. Macrosomia, primary cesarean section, polyhydramnios, 1st and 5th minute apgar scores and hospitalization rates to the neonatal intensive care unit were compared between the groups. Results: While the rate of macrosomia was 18.8% in the patient group, it was 9% in the control group, the difference was statis- tically significant (P = .04). While the rate of primary cesarean section was 22.5% in the patient group, it was 11.5% in the control group (P = .03). While polyhydramnios was seen in 7.5% of the patient group, it was seen in 1.6% of the control group, the difference was statistically significant (P = .03). The number of fetuses with a 1st minute apgar score

Özet

Amaç: Bu çalışmada,100 gram oral glukoz tolerans testi (OGTT)’- deki tek değer yüksekliğinin obstetrik ve perinatal sonuçlarını değerlendirmeyi amaçladık. Gereç ve Yöntem: Çalışmaya retrospektif dosyaları taranarak, 100 gr OGTT tek değer yüksekliği olan 80, açlık kan şekeri ve 50 gr. OGTT’si normal 122 kontrol grubunda hasta dahil edildi. Gruplar arasında makrozomi, primer sezeryan, polihidroamniyoz, 1-5. da- kika apgar skoru ve yenidoğan yoğun bakım ünitesine yatış oranları karşılatırıldı. Bulgular: Makrozomi oranı hasta grubunda %18,8 iken, kontrol grubunda %9 olarak izlendi, fark istatistiksel olarak anlamlıydı (P = .04). Primer sezaryen oranı hasta grubunda %22.5 iken, kontrol grubunda %11.5 olarak izlendi, fark istatistiksel olarak anlamlıydı (P = .03). Polihidroamniyoz hasta grubunun %7.5ʹunda görülür- ken, kontrol grubunun % 1.6’sınde görüldü, aradaki fark istatis- tiksel olarak anlamlıydı (P = .03). Apgar skoru her iki grupta karşılaştırıldığında; 1.dakika apgar skoru

🔖

Cite This Article

Kiremitli, S., Kiremitli, T., Naykı, U. A., Uluğ, P., Uzel, K., Dinç, K., Naykı, C., Yılmaz, B. K., Kurnuç, F. Z., Kırkıncı, A. (2022). The Effect of Single Value Positivity in 100 g OGTT on Maternal and Fetal Outcomes. Archives of Basic and Clinical Research, Cilt: 3 - Sayı: 3, 100–104. https://ajindex.com/articles/447783

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (6)

American Diabetes Association
Classification and diagno- sis of diabetes: Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13-S27. [Crossref] 2. International Diabetes Federation. IDF Diabetes Atlas. 6th Ed. Brussels, Belgium: International Diabetes Federation; 2013
The HAPO Study Cooperative Research Group; Metzger BE, Lowe LP, Dyer AR, Trimble ER. Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medicine. 2008;358(19):1991-2002. [Crossref] 4. Gestational diabetes mellitus. ACOG practice bulletin No
American college of obstetricians and gynecologists. Obstet Gyne- Col. 2018;131(2):e49-e64. [Crossref] 5. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(Supplement 1):S11- S24. [Crossref] 6. Metzger BE, Gabbe SG, Persson B, et al. International asso- ciation of diabetes and pregnancy study groups recommen- dations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-682. [Crossref] 7. Adapted with permission from the American Diabetes As- sociation. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(Supplement 1):S11-S24. [Crossref] 8. Türkiye Endokrinoloji ve Metabolizma Derneği, Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kla- vuzu 7. baskı, Bayt Bilimsel Araştırmalar Basın Yyaın ve Tanıtım Ltd. Şti. 2015; p15-25
Vandorsten JP, Dodson WC, Espeland MA, et al. NIH con- sensus development conference: Diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 2013;29:1-31 10. McLaughlin GB, Cheng YW, Caughey AB. Women with one elevated 3-hour glucose tolerance test value: Are they at risk for adverse perinatal outcomes? American Journal of Obste- trics and Gynecology. 2006;194(5):e16-e19. [Crossref] 11. Ayhan S, Sö A, Güngör T, Özcan U. Prognosis of pregnancies with different degrees of glucose intolerance. Gynecol Obs- tet Reprod Med. 2016;19(2):76-81
Biri A, Korucuoglu U, Ozcan P, Aksakal N, Turan O, Himme- toglu O. Effect of different degrees of glucose intolerance on maternal and perinatal outcomes. J Matern Fetal Neo- natal Med. 2009;22(6):473-478. [Crossref] 13. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144 (7):768-773. [Crossref] 14. Szmuilowicz ED, Josefson JL, Metzger BE. Gestational dia- betes mellitus. Endocrinol Metab Clin North Am. 2019;48 (3):479-493. [Crossref] 15. McInty